Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kaposi's sarcoma presenting as generalized lymphedema

E Frans1, D Blockmans, W Peetermans

  • 1Department of Internal Medicine, Universitaire Ziekenhuizen, K.U. Leuven, Belgium.

Acta Clinica Belgica
|January 1, 1994
PubMed
Summary

A patient with HIV-1 and lymphedema caused by Kaposi's sarcoma, a rare lymphangiomatous variant, was successfully treated with interferon-alpha. This case highlights treatment options for Kaposi's sarcoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cough as a clinical manifestation of giant cell arteritis.

Scandinavian journal of rheumatology·2026
Same author

Flemish network on rare connective tissue diseases (CTD): patient pathways in systemic sclerosis. First steps taken.

Acta clinica Belgica·2023
Same author

Association between diagnostic outcomes and symptom pattern in fever and inflammation of unknown origin.

European journal of internal medicine·2023
Same author

Etiological spectrum and outcome of fever and inflammation of unknown origin. Does symptom duration matter?

European journal of internal medicine·2022
Same author

Rheumatic disorders among patients with fever of unknown origin: A systematic review and meta-analysis.

Seminars in arthritis and rheumatism·2022
Same author

Diagnosis of deficiency of adenosine deaminase type 2 in adulthood.

Scandinavian journal of rheumatology·2021

Area of Science:

  • Oncology
  • Immunology
  • Infectious Diseases

Background:

  • Kaposi's sarcoma (KS) is an opportunistic malignancy associated with Human Immunodeficiency Virus type 1 (HIV-1) infection.
  • A rare lymphangiomatous variant of KS can lead to significant complications like generalized lymphedema.
  • Understanding the diverse presentations of KS is crucial for effective patient management.

Observation:

  • A case of a patient seropositive for HIV-1 presenting with generalized lymphedema is described.
  • The lymphedema was attributed to a lymphangiomatous variant of Kaposi's sarcoma.
  • This specific variant of KS poses unique diagnostic and therapeutic challenges.

Findings:

  • Successful treatment of this rare lymphangiomatous variant of Kaposi's sarcoma was achieved using interferon-alpha.

Related Experiment Videos

  • Interferon-alpha demonstrated efficacy in managing the lymphedema and underlying malignancy.
  • The patient's response to interferon-alpha suggests its potential as a therapeutic agent for this specific KS subtype.

    • Implications:

    • This case expands the known treatment modalities for Kaposi's sarcoma, particularly its rare variants.
    • Interferon-alpha should be considered in the management of lymphangiomatous Kaposi's sarcoma presenting with lymphedema.
    • Further research into targeted therapies for distinct KS subtypes is warranted to improve patient outcomes in HIV-1-positive individuals.